Egis World
Thu, Oct 12, 2023 1:46 PM

Collaboration agreement signed between Egis and the Uzbek Medicines Authority

Egis and the Uzbek Medicines Authority have signed a collaboration agreement in Tashkent to improve pharmaceutical regulations and access to medicines in Uzbekistan.
Egis World

Collaboration agreement signed between Egis and the Uzbek Medicines Authority

Egis and the Uzbek Medicines Authority have signed a collaboration agreement in Tashkent to improve pharmaceutical regulations and access to medicines in Uzbekistan.
Thu, Oct 12, 2023 1:46 PM
Author:
Thu, Oct 12, 2023 1:46 PM
Author:

A collaboration agreement was signed by Egis and the Uzbek Medicines Authority in Tashkent, the capital of Uzbekistan. 
The main objective of both parties is to make high quality medicines more accessible for Uzbek patients, therefore – under the agreement - Egis will provide help to improve pharmaceutical regulations in Uzbekistan as well as support the professional development of the authority’s staff. Frequent exchange of information and experiences between the two parties is an important instrument of the collaboration, it will be paid special attention in the future, according to the agreement.
“Our collaboration helps Uzbek patients have access to high quality and safe medicines at affordable prices, thanks to Egis products”– emphasized Csaba Poroszlai, CEO of Egis at the time of signing the agreement.
Regular consultation and exchange of experiences are key steps for the development of the Uzbek pharma market, which has faced quality issues in recent years. 


The annual turnover of the Uzbek pharmaceutical market is about USD 1.6 billion, over the past 4-5 years, it has consistently experienced double-digit growth. In the long term, Egis expects a similar trend, since the country's population is growing (after this year’s figure of 35.2 million, the population is expected to reach 40 million people by 2030) and its economy expanding (the projected GDP growth of 5.5 percent this year may be followed by a growth of similar pace in the coming years). 
“Besides, a positive factor is the Uzbek state's commitment to improving pharmaceutical regulations and access to medicines and Egis is ready to cooperate with the country on this subject" - said Csaba Poroszlai. 

On behalf of Egis, CEO Csaba Poroszlai, Commercial Operations Director Tamás Uri, General Manager of the Uzbek subsidiary of Egis Khakim Umarov and Miklós Konkoly, Head of Egis' Far East Region while on behalf of the Uzbek Medicines Authorities Agzam Nartaev, Director of the State Center participated in the meeting. The Ministry of Foreign Affairs and Trade of Hungary was represented by János Vanyik, Foreign Trade Attaché.

 

Related articles from Egis Magazine
Egis World

Agreement for Biosimilar Candidates in Key Central and Eastern European Markets
More
Egis World

Ten Years Together – Egis Pharmaceuticals PLC Remains the Partner of the Körmend Basketball Team
More
Egis World

This was the year we commemorated the 110th anniversary of the foundation of our company
More

Cookie Settings

Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings.

Cookies necessary for basic functioning

These cookies ensure the appropriate functioning of the website, facilitate its use and collect information on its use without identifying visitors.

Functional cookies

In order to enhance the user experience, we use cookies which record the use of certain functions of the website, thus enabling users to have the same settings at the time of their next visit.

Cookies for statistical purposes

They provide statistical data on the performance of the website (such as number of page loads, average time spent on the website) in order to collect data for the operator of the website on the website usage patterns of users. These cookies do not identify visitors, information collected by them relate to the number of subpages visited by the user, the length of each session, the types of error messages, etc. Cookies for statistical purposes are automatically placed on the user’s devices during browsing, and you can delete such cookies in the browser settings.
Details
I Agree
WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox